These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 22329848)
1. A subpopulation of CD24⁺ cells in colon cancer cell lines possess stem cell characteristics. Ke J; Wu X; Wu X; He X; Lian L; Zou Y; He X; Wang H; Luo Y; Wang L; Lan P Neoplasma; 2012; 59(3):282-8. PubMed ID: 22329848 [TBL] [Abstract][Full Text] [Related]
2. Identification of cancer stem cell markers in human malignant mesothelioma cells. Ghani FI; Yamazaki H; Iwata S; Okamoto T; Aoe K; Okabe K; Mimura Y; Fujimoto N; Kishimoto T; Yamada T; Xu CW; Morimoto C Biochem Biophys Res Commun; 2011 Jan; 404(2):735-42. PubMed ID: 21163253 [TBL] [Abstract][Full Text] [Related]
3. DNA methyltransferase 1 is essential for initiation of the colon cancers. Morita R; Hirohashi Y; Suzuki H; Takahashi A; Tamura Y; Kanaseki T; Asanuma H; Inoda S; Kondo T; Hashino S; Hasegawa T; Tokino T; Toyota M; Asaka M; Torigoe T; Sato N Exp Mol Pathol; 2013 Apr; 94(2):322-9. PubMed ID: 23064049 [TBL] [Abstract][Full Text] [Related]
4. CD49f-positive cell population efficiently enriches colon cancer-initiating cells. Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747 [TBL] [Abstract][Full Text] [Related]
5. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution. Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779 [TBL] [Abstract][Full Text] [Related]
6. Characterization of side population cells isolated from the colon cancer cell line SW480. Xiong B; Ma L; Hu X; Zhang C; Cheng Y Int J Oncol; 2014 Sep; 45(3):1175-83. PubMed ID: 24926880 [TBL] [Abstract][Full Text] [Related]
7. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line. Zhang H; Li W; Nan F; Ren F; Wang H; Xu Y; Zhang F Biochem Biophys Res Commun; 2011 Jan; 404(1):273-8. PubMed ID: 21130073 [TBL] [Abstract][Full Text] [Related]
9. Human colorectal CD24+ cancer stem cells are susceptible to epithelial-mesenchymal transition. Okano M; Konno M; Kano Y; Kim H; Kawamoto K; Ohkuma M; Haraguchi N; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M; Ishii H Int J Oncol; 2014 Aug; 45(2):575-80. PubMed ID: 24858473 [TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties. Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394 [TBL] [Abstract][Full Text] [Related]
11. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574 [TBL] [Abstract][Full Text] [Related]
12. Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method. Kai M; Onishi H; Souzaki M; Tanaka H; Kubo M; Tanaka M; Katano M Cancer Sci; 2011 Dec; 102(12):2132-8. PubMed ID: 21838786 [TBL] [Abstract][Full Text] [Related]
13. Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells. Yamazaki H; Naito M; Ghani FI; Dang NH; Iwata S; Morimoto C Biochem Biophys Res Commun; 2012 Mar; 419(3):529-36. PubMed ID: 22369943 [TBL] [Abstract][Full Text] [Related]
14. Impact of cell dissociation on identification of breast cancer stem cells. Quan Y; Yan Y; Wang X; Fu Q; Wang W; Wu J; Yang G; Ren J; Wang Y Cancer Biomark; 2012-2013; 12(3):125-33. PubMed ID: 23481571 [TBL] [Abstract][Full Text] [Related]
15. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181 [TBL] [Abstract][Full Text] [Related]
16. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant. Farnie G; Sotgia F; Lisanti MP Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710 [TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines. Michishita M; Akiyoshi R; Suemizu H; Nakagawa T; Sasaki N; Takemitsu H; Arai T; Takahashi K Vet J; 2012 Aug; 193(2):508-13. PubMed ID: 22326935 [TBL] [Abstract][Full Text] [Related]
18. SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers. Suzuki Y; Haraguchi N; Takahashi H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Ishii H; Doki Y; Mori M; Yamamoto H Int J Oncol; 2013 Jan; 42(1):161-7. PubMed ID: 23175153 [TBL] [Abstract][Full Text] [Related]
19. Identification of human pancreatic cancer stem cells. Li C; Lee CJ; Simeone DM Methods Mol Biol; 2009; 568():161-73. PubMed ID: 19582426 [TBL] [Abstract][Full Text] [Related]
20. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells. El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]